IDH3A antibody (A09544-3) performs well in ELISA, Flow Cytometry, IF, IHC, ICC, WB and shows reactivity with Human, Mouse, Rat.

  • Validated for inter-lot consistency, specificity, and reproducibility
  • Committed to quality since 1993
Filter:
a09544 3 idh3a primary antibodies fcm testing 8a09544 3 idh3a primary antibodies if testing 6a09544 3 idh3a primary antibodies if testing 7a09544 3 idh3a primary antibodies ihc testing 2a09544 3 idh3a primary antibodies ihc testing 3a09544 3 idh3a primary antibodies ihc testing 4a09544 3 idh3a primary antibodies if testing 5a09544 3 idh3a primary antibodies wb testing 1

Designing an IHC experiment for IDH3A? The guide covers the expected staining pattern, antigen retrieval, antibodies backed by real IHC images, tissue controls, and protocols taken from published papers.
Open the IDH3A IHC Guide

Anti-IDH3A Antibody Picoband®

IDH3A antibody

Reactive SpeciesHostApplication
Human, Mouse, RatRabbitELISA, Flow Cytometry, IF, IHC, ICC, WB

SKU: A09544-3

Size: 100 µg

Bundle to save: I do not want free secondary ab
Price:
$370/100 µg

In stock. Ships Next Business Day.

Quantity: 1

1
Get A Quote
Guarantee / Product Promise

Tested Applications

IDH3A antibody was positively detected by WB in:

human HepG2 whole cell, human Hela whole cell, rat brain tissue, rat heart tissue, mouse brain tissue, mouse heart tissue

Suggested blocking solution with 5% non-fat milk or BSA; (*)Recommended protein loading: 20-40 ug per lane

IDH3A antibody was positively detected by IHC in:

human esophageal squamous carcinoma tissue, human rectum adenocarcinoma tissue, rat heart tissue

Use EDTA pH 8.0 for antigen retrieval; (*) citrate buffer pH 6.0 is an alternative.

IDH3A antibody was positively detected by ICC/IF in:

PC-3 cell

IDH3A antibody was positively detected by IF in:

human liver cancer tissue, human intestinal cancer tissue

IDH3A antibody was positively detected by FC in:

HepG2 cell

Recommend Dilution

Application
Dilution
Species
Western blot
0.25-0.5 μg/ml
Human, Mouse, Rat
Immunohistochemistry(Paraffin-embedded Section)
2-5 μg/ml
Human, Rat
Immunocytochemistry/Immunofluorescence
5 μg/ml
Human
Immunofluorescence
5 μg/ml
Human
Flow Cytometry (Fixed)
1-3 μg/1x106 cells
Human
ELISA
0.1-0.5 μg/ml
-

* It is recommended to optimize the amount of this reagent in each experimental system to achieve the best results.

Note: For flow cytometry (FCM), suitable for fixed cells only. Not suitable for FACS or surface flow cytometry using live cells.

Reactive Data

Filter:
Boster Guarantee:What is this?
WB
IHC
IF
ELISA
Human
Tested
Tested
Tested
Recommend
Rat
Tested
Tested
Recommend
Recommend
Mouse
Tested
Recommend
Monkey
Predicted
Predicted
Predicted
Predicted
Rabbit
Predicted
Predicted
Predicted
Predicted
Dog
Predicted
Predicted
Predicted
Predicted
Sheep
Predicted
Predicted
Predicted
Predicted
Bovine
Predicted
Predicted
Predicted
Predicted

Product Information

Product Name
Anti-IDH3A Antibody Picoband®
View all IDH3A Antibodies
Form
Lyophilized
Uniprot
Gene ID
Storage & Handling
At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.
Host
Rabbit
Contents
Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
Clonality
Polyclonal
Isotype
IgG
Immunogen
E.coli-derivedhumanIDH3Arecombinantprotein(Position:K9-D366).HumanIDH3Ashares98%and97.8%aminoacid(aa)sequenceidentitywithmouseandratIDH3A,respectively.
Cross-Reactivity
No cross reactivity with other proteins.
Reconstitution
Adding 0.2 ml of distilled water will yield a concentration of 500 µg/ml.
Observed Molecular Weight
37 kDa
Calculated Molecular Weight

39.6 kDa

Background of IDH3A
Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (IDH3α) is an enzyme that in humans is encoded by the IDH3A gene. Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit. The protein encoded by this gene is the alpha subunit of one isozyme of NAD(+)-dependent isocitrate dehydrogenase.
Cite This Product
Anti-IDH3A Antibody Picoband® (Boster Biological Technology, Pleasanton CA, USA, Catalog # A09544-3)

Protocols

Western Blot protocol for IDH3A antibody
Immunohistochemistry (IHC) protocol for IDH3A antibody
Immunocytochemistry/Immunofluorescence (ICC/IF) protocol for IDH3A antibody
Immunofluorescence (IF) protocol for IDH3A antibody
Flow Cytometry (FC) protocol for IDH3A antibody

Review

Have you used Anti-IDH3A Antibody Picoband®?

Submit a review and receive $370 in product credits, a $185 Amazon gift card, or our carefully curated gift bundles.

Product Promise

We promise Anti-IDH3A Antibody Picoband® performs excellently in relevant applications for ELISA, Flow Cytometry, IF, IHC, ICC, WB. If it doesn't perform as promised, we will refund the product. Learn more

In stock
Order Product
A09544-3
Buy one primary antibody get one 0.5ml HRP or Biotin secondary antibody for free.
*Sample sizes are prepared on demand and will take extra lead time. (cannot be conjugated)
$370.00

Troubleshooting

troubleshooting-box-image

Download troubleshooting handbooks for IHC, Western blot and ELISA for FREE.

Download Free PDFs Now

Boster Guarantee

Guaranteed product quality

Guaranteed product quality

We promise all of our products perform as described in datasheets.

This product is for Research Use Only. Not for use in diagnostic procedures.

Update date: Nov 1, 2026